These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 20823781

  • 1. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A, Seth A, Kaur S, Aneja S, Rath B, Basu S, Patel R, Dutta AK.
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [Abstract] [Full Text] [Related]

  • 2. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
    Thakur CP, Thakur S, Narayan S, Sinha A.
    Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
    [Abstract] [Full Text] [Related]

  • 3. Antimony-induced cerebellar ataxia.
    Khalil EA, Ahmed AE, Musa AM, Hussein MH.
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [Abstract] [Full Text] [Related]

  • 4. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D.
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [Abstract] [Full Text] [Related]

  • 5. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK.
    Natl Med J India; 2005 Aug; 18(3):131-3. PubMed ID: 16130613
    [Abstract] [Full Text] [Related]

  • 6. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB, Yang CM, Zhang CJ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract] [Full Text] [Related]

  • 7. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, Bhattacharya SK, Sinha A.
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [Abstract] [Full Text] [Related]

  • 8. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H, Sharma KK, Rijal S, Dwivedi S, Koirala S.
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [Abstract] [Full Text] [Related]

  • 9. Amphotericin B in resistant kala-azar in Bihar.
    Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK.
    Natl Med J India; 1993 Jul; 6(2):57-60. PubMed ID: 8477209
    [Abstract] [Full Text] [Related]

  • 10. Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.
    Ghosh S, Verma A, Kumar D, Deep DK, Ramesh V, Salotra P, Singh R.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0402623. PubMed ID: 38712926
    [Abstract] [Full Text] [Related]

  • 11. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.
    Thakur CP, Narayan S, Ranjan A.
    Indian J Med Res; 2004 Sep 04; 120(3):166-72. PubMed ID: 15489554
    [Abstract] [Full Text] [Related]

  • 12. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S, Mandal A, Duttagupta S.
    Indian J Exp Biol; 2001 Mar 04; 39(3):249-54. PubMed ID: 11495284
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar.
    Thakur CP, Sinha GP, Sharma V, Pandey AK, Kumar M, Verma BB.
    Indian J Med Res; 1993 Jul 04; 97():170-5. PubMed ID: 8406644
    [Abstract] [Full Text] [Related]

  • 14. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P.
    J Infect Dis; 2006 Aug 01; 194(3):302-6. PubMed ID: 16826477
    [Abstract] [Full Text] [Related]

  • 15. Injectable paromomycin for Visceral leishmaniasis in India.
    Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK.
    N Engl J Med; 2007 Jun 21; 356(25):2571-81. PubMed ID: 17582067
    [Abstract] [Full Text] [Related]

  • 16. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P, Koirala S, Parija SC, Hansdak SG, Das ML.
    Southeast Asian J Trop Med Public Health; 1998 Mar 21; 29(1):154-8. PubMed ID: 9740292
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
    Singh S, Kumar J, Singh R, Dwivedi SN.
    Int J Infect Dis; 2000 Mar 21; 4(4):203-8. PubMed ID: 11231183
    [Abstract] [Full Text] [Related]

  • 18. Treatment of kala-azar in India.
    Thakur CP.
    Natl Med J India; 1992 Mar 21; 5(5):203-5. PubMed ID: 1338871
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine.
    Thakur CP, Kumar A, Mitra G, Thakur S, Thakur M.
    Indian J Med Res; 2007 Jul 21; 126(1):73-5. PubMed ID: 17890828
    [Abstract] [Full Text] [Related]

  • 20. Sodium antimony gluconate, amphotericin, and myocardial damage.
    Thakur CP.
    Lancet; 1998 Jun 27; 351(9120):1928-9. PubMed ID: 9654264
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.